TrialPathology oncology research : POR2020

Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy.

Yung-Sung Yeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.